Cell culture and animals. Murine breast cancer (4T1), human lung adenocarcinoma (A549) and 33 human colon carcinoma (Caco-2) cells were purchased from KeyGEN Biotech Co., Ltd. (Nanjing, 34 China). 4T1 and A549 cells were cultured in RPMI 1640 medium supplemented with 10% FBS, 35 100 µg/mL streptomycin and 100 U/mL penicillin. Caco-2 cells were cultured in DMEM 36 supplemented with 10% FBS, 1% non-essential amino acids, 1% L-glutamine, 100 µg/mL 37 streptomycin and 100 U/mL penicillin. All cells were cultured in an incubator at 37 °C with a 38 humidified atmosphere of 5% CO 2 . Fig. S1 ) 1 . Briefly, 5 mL of 20% (w/v) BSA solution was 47 slowly added to 125 mL of an ethylenediamine solution (0.9 M, pH 4.75) under stirring. 48
Subsequently, 200 mg of EDC was added, and then, the mixture was stirred at room temperature for 49 2 h. The reaction was quenched by the addition of 650 μL acetate buffer (4 M, pH 4.75). Then, the 50 reaction solution was concentrated to approximately 10 mL by a protein concentrator (Thermo 51
Fisher, USA)), followed by dialysis against distilled water using a dialysis bag (MWCO 3500) for 52 72 h, and finally freeze-dried to obtain CBSA. BSA and CBSA were characterized by isoelectric 53
focusing (IEF). 54
Characterization of core-shell nanocarriers. 55
Morphology. The morphologies of the BNCs, DNCs and CNCs were investigated using a 56 transmission electron microscope (TEM). The nanocarrier samples were diluted appropriately in 57 distilled water, and one drop was placed on a carbon-coated copper grid, followed by air drying and 58 staining with 2% (w/v) phosphotungstic acid for 30 s at room temperature for contrast enhancement. 59
Finally, the sample was observed by TEM (JEM-1230, Tokyo, Japan) after air drying. 60
Particle size, size distribution and zeta potential. The particle size, size distribution and zeta 61 potential of the BNCs, DNCs and CNCs were measured using a Zetasizer 3000 HSA (Malvern 62 Instruments Ltd., UK) according to the dynamic light scattering (DLS) principle. The samples were 63 diluted appropriately in distilled water before measurement. Determinations were performed at 633 64 nm with a constant scattering angle of 90° at 25 °C. The size distribution was indicated by the 65 polydispersity index (PDI), and the raw data were expressed by the intensity-weighted Gaussian 66 distribution (with Chi-squared value < 3). Each batch was carried out in triplicate. 67
Core-shell structure confirmation. The core-shell structure of nanocarriers was confirmed by 68 confocal laser scanning microscopy (CLSM). Dual fluorescence-labeled microscale carriers labeled 69 with C6 and rhodamine B isothiocyanate (RBITC) were prepared using a procedure similar to the 70 fabrication of BNCs. Briefly, the oil phase containing C6 (0.3 mg), EP (100 mg) and Labrafil ® M 71 1944 CS (1 mL) was added to the aqueous phase containing 30 mL of 1.0% (w/v) RBITC-labeled 72 CBSA and followed by dispersing at 10 000 rpm for 60 s using a high-speed disperser as described 73 above. The suspension was diluted appropriately in distilled water and one drop of the sample was 74 placed on the surface of a glass slide. After covering with a cover slip, the sample was observed by 75 CLSM (Zeiss LSM 700, Germany). To evaluate the protection for miRNA-34a against RNase A degradation by CNCs, free 84 miRNA-34a (0.5 µg) and CNCs (containing 0.5 µg miRNA-34a) were incubated with RNase A 85 (final concentration 10 µg/mL) at 37 °C for the indicated times. The resulting samples were 86 terminated by incubation with SDS (final concentration 1%) for 5 min at 60 °C, and then heparin 87 (final concentration 2%) was added to the samples to displace miRNAs from CNCs. Finally, the 88 samples were analyzed by agarose gel electrophoresis as described above. 89
To assess the serum stability of miRNA-34a in CNCs, free miRNA-34a (0.5 µg) and CNCs 90 (containing 0.5 µg miRNA-34a) were incubated in 10% FBS solution (final concentration) at 37 °C 91 for the indicated periods. Then, the samples were picked out, processed according to the procedure 92 described above and finally analyzed by agarose gel electrophoresis. In vitro leakage of C6 and Cy5-RNA from CNCs. Briefly, 1 mL of dual fluorescence-labeled 115
CNCs suspension were placed in two dialysis tubes with a molecular weight cutoff of 12 kDa for 116 C6 and 50 kDa for Cy5-RNA, respectively. Then, the dialysis tubes were located in 10 mL of 117 serum-free medium at 37 °C and under moderate shaking using a horizontal shaking incubator 118 (SHA-C, Jintan, China). At indicated time intervals, 0.3 mL of release medium were taken out from 119 the dialysate and replaced by an equal volume of release medium. In addition, C6 release from 120 C6 CNCs and Cy5-RNA release from CNCs Cy5-RNA were also measured in the same method. The 121 concentration of C6 and Cy5-RNA were detected using a hybrid multi-mode microplate reader 122 (POLARstar Omega, BMG Labtech, Germany). The excitation wavelength and the emission 123 wavelength were set at 488 nm and 520 nm for C6, 630 nm and 670 nm for Cy5-RNA, respectively. 124
Each sample was carried out in triplicate. Chemi XR5 (Syngene, Cambridge, UK). GAPDH was used as an internal control to normalize the 178 protein expression. 179
Cell cytotoxicity and apoptosis assays. Cell cytotoxicity was assessed by the MTT method. 180
Briefly, 4T1 cells were seeded with a density of 5×10 3 cells/well in 96-well plates and cultured for 181 8 24 h for cell attachment. Then, the cells were exposed to fresh culture medium containing BNCs, 182 DTX, DNCs, RNCs and CNCs, respectively. The concentration of miRNA-34a was fixed at 100 nM 183 and the concentrations of DTX were set as 0.01, 0.1, 1, 10 and 50 µg/mL. After incubation for 48 h, 184 20 µL MTT (5 mg/mL) was added to each well, and the cells were incubated for an additional 4 h. 185
The medium was removed, and then, 200 µL of dimethyl sulfoxide (DMSO) was added to each well 186 to dissolve formazan crystals. Finally, the absorbance at 570 nm was measured using a Microplate 187
Reader (Multiskan FC, USA). The cell viability was calculated by the following formula 
